C7 – Cancer Peptides Selective peptide ligand for FRalpha, demonstrating specific binding to FRalpha expression cells and tumour targeting ability in vivo. Technical specification Sequence : H-MHTAPGWGYRLS-OH MW : 1.374.7 g/mol Purity : > 95% Counter-Ion : TFA Salts Delivery format : Lyophilized Price Product Size Price € Price $ CRB1001181-0.5 mg 0.5 […]
| Sequence: | H-MHTAPGWGYRLS-OH |
| Purity: | > 95% (by HPLC) |
| Counter-Ion: | TFA Salts |
| Delivery Format: | Lyophilized |
Selective peptide ligand for FRalpha, demonstrating specific binding to FRalpha expression cells and tumour targeting ability in vivo.
| Sequence : | H-MHTAPGWGYRLS-OH | |
| MW : | 1.374.7 g/mol | |
| Purity : | > 95% | |
| Counter-Ion : | TFA Salts | |
| Delivery format : | Lyophilized |
| Product | Size | Price € | Price $ |
| CRB1001181-0.5 mg | 0.5 mg | 141€ | 170$ |
| CRB1001181-1 mg | 1 mg | 193€ | 232$ |
